By Staff
Friday, May 3, 2024 12:27 AM
NEW YORK—The national average for gross revenue at ECP locations decreased last week, April 22–28, when compared with the previous week at a rate of -2 index points. That places gross revenue at a level 5 index points above where it was at this point in time (Week 17) when compared with last year (2023), 11 points above the same period in 2022, 14 points above 2021, 102 points above 2020 (during COVID) and 19 points above 2019, according to Jobson’s most recent Practice Performance Tracker.
By Staff
Friday, May 3, 2024 12:24 AM
ALISO VIEJO, Calif.—
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company focused on therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, has announced financial results for the first quarter ended March 31, 2024.
By Staff
Friday, May 3, 2024 12:18 AM
BOSTON—The board of trustees at
New England College of Optometry (NECO) has announced its honorary degree recipient, two Presidential Medal awardees, and six valedictorians as part of its 130th commencement exercises to be held on May 19, 2024, at Boston’s Symphony Hall. Myopia expert and research leader Jane Gwiazda, Ph.D., is the honorary degree recipient. Marge Axelrad, editorial director emeritus of
Vision Monday and
VMAIL, and Marc Ferrara, executive consultant for Jobson Optical Group, will receive the Presidential Medal awards.
By Staff
Friday, May 3, 2024 12:15 AM
BOSTON—
20/20 Onsite, a mobile eyecare company, is partnering with Southbridge Public Schools (SPS) and the
Health Foundation of Central Massachusetts to provide comprehensive eye exams and glasses to SPS students at no cost to their families through the “Vision for Southbridge” program.
By Staff
Thursday, May 2, 2024 12:27 AM
VAUGHAN, Ontario—
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced its first-quarter 2024 financial results. The company reported that revenue grew 18 percent (20 percent on a constant currency basis) compared with the first quarter of 2023, driven by growth across all business segments. The company also raised full-year 2024 constant currency revenue growth guidance to 13 percent to 15 percent and the full-year revenue range to between $4.600 billion and $4.700 billion.
By Staff
Thursday, May 2, 2024 12:21 AM
LAKE FOREST, Calif.—
STAAR Surgical Company, developer, manufacturer and marketer of the EVO family of implantable collamer lenses (EVO ICL) for myopia, astigmatism and presbyopia, has announced that Nancy Sabin has been named chief marketing officer and Nathaniel Sisitsky has been named general counsel.
By Staff
Thursday, May 2, 2024 12:18 AM
TORONTO, Canada—
RetiSpec, Inc., an innovator in artificial intelligence-powered eye diagnostics for brain health, and
Topcon Healthcare, Inc., a provider of medical devices and software solutions, have announced that Topcon has invested in RetiSpec, and the two companies are collaborating to bring RetiSpec technology to market.
By Staff
Thursday, May 2, 2024 12:15 AM
CHARENTON-LE-PONT, FRANCE—To honor this year’s Presbyopia Awareness Month, the
World Council of Optometry (WCO), in partnership with
EssilorLuxottica, has announced the release of the global standard of care for presbyopia and the aging eye. According to the announcement, the aim of this resolution is to set a benchmark through evidence-based resources that center on the eyecare practitioner's attention toward the three pillars of mitigating, measuring and managing presbyopia.
By Staff
Wednesday, May 1, 2024 12:24 AM
SAN DIEGO—
Toku, Inc., a commercial medical device company specializing in imaging technology and artificial intelligence, has announced that the U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to its MyKidneyAI technology, which uses AI to analyze retinal images collected at routine eye exams to detect elevated chronic kidney disease risk in people with diabetes.
By Staff
Wednesday, May 1, 2024 12:21 AM
MIAMI—
Innovative Eyewear, Inc., developer and seller of smart eyewear, has announced that it has entered into a definitive agreement for the issuance and sale of 4,200,822 shares of its common stock at a purchase price per share of $0.244 in a registered direct offering.
By Staff
Wednesday, May 1, 2024 12:15 AM
ALISO VIEJO, Calif.—
Glaukos, an ophthalmic pharmaceutical and medical technology company with a focus on patient education about keratoconus (KC), announced it has been honored with a Stevie Award for Marketing Campaign of the Year for its multifaceted KC Consumer Awareness Campaign. The bronze level distinction from the American Business Association recognizes the consumer awareness focus of the campaign, created with agency partner PRECISIONeffect. The campaign, centered around its
“Living With KC” website, is supported by social media and collateral materials breaking down KC signs and symptoms, risks, and possible rapid progression.
By Staff
Tuesday, April 30, 2024 12:27 AM
WASHINGTON, D.C.—The
Contact Lens Institute (CLI) has published an in-depth report on everyday actions that the eyecare community can take to draw interest from potential and former contact lens wearers. Based on research with more than 1,000 vision-corrected adults segmented by glasses-only wearers, new contact lens wearers, and former contact lens wearers,
“Beyond Vision: Behaviors to Attract New & Returning Contact Lens Wearers" is the latest offering from CLI’s See Tomorrow initiative. The 26-page document includes multiple infographics depicting high-value takeaways that can be used for staff training.
By Staff
Tuesday, April 30, 2024 12:18 AM
NEW YORK—The readers of
Vision Monday and
20/20 Magazine are being asked once again to
share nominations for their Ultimate Partners. Now in it's fourth year, Jobson’s 2024 Ultimate Partners program allows readers to highlight their great business support partners and showcase their support. Open to all eyecare professionals, the program is looking to spotlight your most successful collaborations and celebrate the crucial support shared during both challenges and opportunities.